Higher frequency asymmetry in the grayscale distribution indicates greater tumor heterogeneity and contributes to distinguishing between HER2-low and HER2-negative tumors, potentially influenced by factors such as cell proliferation time, necrosis, and microcalcification (40). The gene discussed is ERBB2; the disease is neoplasm.